Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors
C Simoens, PPL Martin‐Hirsch - Cochrane database of …, 2018 - cochranelibrary.com
Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …
causally linked with the development of cervical precancer and cancer. HPV types 16 and …
[HTML][HTML] Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review
T Harder, O Wichmann, SJ Klug, MAB van der Sande… - BMC medicine, 2018 - Springer
Background Human papillomavirus (HPV) vaccination is safe and effective in preventing
cervical cancer in females. As HPV infections can also induce cancers of the anus, penis …
cervical cancer in females. As HPV infections can also induce cancers of the anus, penis …
[HTML][HTML] HPV carcinomas in immunocompromised patients
NM Reusser, C Downing, J Guidry… - Journal of clinical medicine, 2015 - mdpi.com
Human papillomavirus (HPV) infection is the most common sexually transmitted disease
worldwide and can result in pre-malignancies or overt malignancies of the skin and mucosal …
worldwide and can result in pre-malignancies or overt malignancies of the skin and mucosal …
[HTML][HTML] Oral cancer, HPV infection and evidence of sexual transmission
F Martín-Hernán, JG Sánchez-Hernández… - … oral, patologia oral y …, 2013 - ncbi.nlm.nih.gov
The incidence of oropharyngeal cancer and oral cancer is growing worldwide, both in young
non-smokers and in young non-drinkers (smoking and drinking are considered the main risk …
non-smokers and in young non-drinkers (smoking and drinking are considered the main risk …
[HTML][HTML] Summary of the evidence on the safety, efficacy, and effectiveness of human papillomavirus vaccines: Umbrella review of systematic reviews
Background This objective of this umbrella review was to summarize the evidence on safety,
efficacy, and effectiveness of human papillomavirus (HPV) vaccines in the general …
efficacy, and effectiveness of human papillomavirus (HPV) vaccines in the general …
[HTML][HTML] Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
LM Branco, JN Grove, FJ Geske, ML Boisen, IJ Muncy… - Virology journal, 2010 - Springer
Background Lassa fever is a neglected tropical disease with significant impact on the health
care system, society, and economy of Western and Central African nations where it is …
care system, society, and economy of Western and Central African nations where it is …
[HTML][HTML] Effect of an educational intervention on HPV knowledge and attitudes towards HPV and its vaccines among junior middle school students in Chengdu, China
CR Liu, H Liang, X Zhang, C Pu, Q Li, QL Li, FY Ren… - BMC Public Health, 2019 - Springer
Background Little is known about the knowledge and attitudes towards human
papillomavirus (HPV) and its vaccines among adolescents in mainland China. Also, limited …
papillomavirus (HPV) and its vaccines among adolescents in mainland China. Also, limited …
Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases
SR Skinner, D Apter, N De Carvalho… - Expert review of …, 2016 - Taylor & Francis
Vaccines are available against human papillomavirus (HPV), the causal agent of cervical
and other cancers. Efficacy data from the HPV-16/18 AS04-adjuvanted vaccine clinical trial …
and other cancers. Efficacy data from the HPV-16/18 AS04-adjuvanted vaccine clinical trial …
HPV vaccine acceptability and willingness-related factors among Chinese adolescents: a nation-wide study
X Zhang, Z Wang, Z Ren, Z Li, W Ma… - Human Vaccines & …, 2021 - Taylor & Francis
Background Adolescents are the primary target population for human papillomavirus (HPV)
vaccination. The objective of this study is to explore the acceptability of HPV vaccines and …
vaccination. The objective of this study is to explore the acceptability of HPV vaccines and …
[HTML][HTML] The efficacy and duration of vaccine protection against human papillomavirus: a systematic review and meta-analysis
Y Delere, O Wichmann, SJ Klug… - Deutsches Ärzteblatt …, 2014 - ncbi.nlm.nih.gov
Background The German Standing Committee on Vaccination (STIKO) recommends
vaccination against human papillomaviruses (HPV) of the high-risk types 16 and 18. The …
vaccination against human papillomaviruses (HPV) of the high-risk types 16 and 18. The …